Brand profile · Biotechnology

Chugai Pharmabody Research

Chugai Pharmabody Research runs a Biotechnology operation from Singapore. Publicly held, at chugai-pharmabody.com. It holds one address on record, all in Singapore. It employs 126 people, on the record. It lists antibody Drug Discovery, antibody Engineering Technology and innovative Antibody Drug among its specialties. One Singapore registration (UEN) is a confirmed match. The record links two similar brands, most of them in Biotechnology.

Profile live Public Company Founded 2012 1 entity UEN 1 office country
Registry verified · ACRA

Key facts

Counted staff
126
self-reported 51–200 band
Founded
2012
14 years
Legal entities
1
ACRA
Office countries
1
1 address
Funding rounds
None on record
Company type
Public Company
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity

Legal entities

Chugai Pharmabody Research: 1 registry entityChugai Pharmabody Research is linked to 1 registry entity: CHUGAI PHARMABODY RESEARCH PTE. LTD. (UEN 201135838E, confirmed).Chugai Pharmabody ResearchCHUGAI PHARMABODYRESEARCH PTE. LTD.UEN 201135838EConfirmed · ACRA
Show as table · Chugai Pharmabody Research: 1 registry entity
Chugai Pharmabody Research: 1 registry entity
CHUGAI PHARMABODY RESEARCH PTE. LTD.UEN 201135838E
Confirmed matches1 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

In the global medical field, there are many diseases in which there are no drug or current drugs are insufficient to address the medical needs of patients. Chugai Pharmabody Research (CPR) is a subsidiary company of Chugai Pharmaceutical in Japan, a member of Roche group, and is committed to address these unmet needs by specializing in the field of antibody drug discovery utilizing proprietary antibody engineering technologies.

Specialties

All 6 specialties
  • Antibody Drug Discovery
  • Antibody Engineering Technology
  • Innovative Antibody Drug
  • Recycling Antibody
  • Sweeping Antibody
  • Bispecific Antibody

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary SG. Codes: SG.1 countryprimary SGSG
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countrySG

All codes: SG

Addresses

  • SG3 Biopolis Dr; #07 -11 to 16; Singapore, Singapore 138623Primary

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

The people relation is never requested, so there is nothing here to unlock.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under Chugai Pharmabody Research?

One Singapore entity on ACRA: CHUGAI PHARMABODY RESEARCH PTE. LTD. (UEN 201135838E), high confidence.

How many people work at Chugai Pharmabody Research?

126 counted staff profiles at January 2026, inside the self-reported 51–200 band.

Where does Chugai Pharmabody Research have offices?

One address on record, Singapore only. Primary: 3 Biopolis Dr, #07 -11 to 16, Singapore 138623.

Has Chugai Pharmabody Research raised funding?

None linked to this brand.

What does Chugai Pharmabody Research list as its specialties?

Six tags on the brand's own list, among them Antibody Drug Discovery, Antibody Engineering Technology and Innovative Antibody Drug.

Which companies are listed alongside Chugai Pharmabody Research?

3 profiles list Chugai Pharmabody Research as a peer — 50th percentile in Biotechnology. It lists ten peers of its own.

What is Chugai Pharmabody Research's website?